NextCure (NXTC) Earnings Analysis
NextCure (NXTC) next reports earnings on 2026-08-06, consensus EPS -1.98 USD. Last quarter (2026-05-07) it missed with EPS -1.87 USD vs -1.81 USD est (-3.3%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -0.23.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NXTC next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.98 USD |
| Revenue estimate | n/a |
NXTC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -1.87 USD | -1.81 USD | -3.3% | Miss |
| 2026-03-05 | -0.81 USD | -2.26 USD | +64.2% | Beat |
| 2025-08-07 | -11.29 USD | -4.62 USD | -144.4% | Miss |
| 2025-05-01 | -4.68 USD | -4.8 USD | +2.5% | Beat |
| 2025-03-06 | -4.92 USD | -4.08 USD | -20.6% | Miss |
| 2024-11-07 | -4.92 USD | -4.2 USD | -17.1% | Miss |
| 2024-08-01 | -6.6 USD | -4.32 USD | -52.8% | Miss |
Beat rate: 2/7 (29%) over reported quarters with consensus data.
NXTC valuation and analyst view
| Trailing P/E | -0.23 |
|---|---|
| Trailing EPS | -10.43358 USD |
| Price / book | 0.86 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (11 buy / 1 hold / 1 sell) |
| Avg price target | 20 USD |
Related research pages
Frequently asked questions
When is NextCure (NXTC)'s next earnings date?
NextCure is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.98 USD.
Did NXTC beat earnings last quarter?
In its 2026-05-07 report, NXTC posted EPS of -1.87 USD versus a -1.81 USD estimate — a miss of 3.3%.
What is NXTC's earnings track record?
Over the last 7 reported quarters with consensus data, NXTC beat estimates 2 times (29%).
What is NXTC's current P/E ratio and EPS?
NXTC trades at a trailing P/E of -0.23 on trailing EPS of -10.4335823009309 USD.
What do analysts rate NXTC?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 11 buy, 1 hold, 1 sell, 0 strong sell). Average 12-month price target: 20 USD.